These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 27288277)

  • 1. Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery.
    Dhillon A; Khanna A; Randhawa MS; Cywinski J; Saager L; Thamilarasan M; Lever HM; Desai MY
    Heart; 2016 Oct; 102(20):1627-32. PubMed ID: 27288277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncardiac surgery and the risk of death and other cardiovascular events in patients with hypertrophic cardiomyopathy.
    Hreybe H; Zahid M; Sonel A; Good CB; Shaver J; Saba S
    Clin Cardiol; 2006 Feb; 29(2):65-8. PubMed ID: 16506641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes.
    Desai MY; Bhonsale A; Patel P; Naji P; Smedira NG; Thamilarasan M; Lytle BW; Lever HM
    JACC Cardiovasc Imaging; 2014 Jan; 7(1):26-36. PubMed ID: 24290569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Rowin EJ; Hausvater A; Link MS; Abt P; Gionfriddo W; Wang W; Rastegar H; Estes NAM; Maron MS; Maron BJ
    Circulation; 2017 Dec; 136(25):2420-2436. PubMed ID: 28916640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and Long-Term Outcomes of Patients With Hypertrophic Cardiomyopathy After Noncardiac Surgery: A Single-Center Retrospective Study.
    Yatabe T; Kubo T; Kitaoka H; Yokoyama M
    J Cardiothorac Vasc Anesth; 2019 Jan; 33(1):109-114. PubMed ID: 29605142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical course after catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Higuchi S; Ejima K; Minami Y; Ooyabu K; Iwanami Y; Yagishita D; Shoda M; Hagiwara N
    Heart Vessels; 2019 Mar; 34(3):527-537. PubMed ID: 30255478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health records.
    Pujades-Rodriguez M; Guttmann OP; Gonzalez-Izquierdo A; Duyx B; O'Mahony C; Elliott P; Hemingway H
    PLoS One; 2018; 13(1):e0191214. PubMed ID: 29324812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience.
    Steggerda RC; Damman K; Balt JC; Liebregts M; ten Berg JM; van den Berg MP
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1227-34. PubMed ID: 25326737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.
    Ommen SR; Maron BJ; Olivotto I; Maron MS; Cecchi F; Betocchi S; Gersh BJ; Ackerman MJ; McCully RB; Dearani JA; Schaff HV; Danielson GK; Tajik AJ; Nishimura RA
    J Am Coll Cardiol; 2005 Aug; 46(3):470-6. PubMed ID: 16053960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device.
    Wilke I; Witzel K; Münch J; Pecha S; Blankenberg S; Reichenspurner H; Willems S; Patten M; Aydin A
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):779-84. PubMed ID: 27060297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular outcomes by time-varying New York Heart Association class among patients with obstructive hypertrophic cardiomyopathy: a retrospective cohort study.
    Wang Y; Gao W; Han X; Jiang J; Sandler B; Li X; Zema C
    J Med Econ; 2023; 26(1):1495-1506. PubMed ID: 37902966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy.
    Samardhi H; Walters DL; Raffel C; Rateesh S; Harley C; Burstow D; Pohlner P; Aroney C
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):270-7. PubMed ID: 23873660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age.
    Maron BJ; Rowin EJ; Casey SA; Haas TS; Chan RH; Udelson JE; Garberich RF; Lesser JR; Appelbaum E; Manning WJ; Maron MS
    Circulation; 2013 Feb; 127(5):585-93. PubMed ID: 23275385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Septal Reduction Therapy on Acute Cardiovascular Events and All-Cause Mortality in Patients with Hypertrophic Cardiomyopathy.
    Morita SX; Zhao Y; Hasegawa K; Fifer MA; Maurer MS; Reilly MP; Takayama H; Shimada YJ
    Int Heart J; 2021 Sep; 62(5):1035-1041. PubMed ID: 34544977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of apical cavity obliteration in apical hypertrophic cardiomyopathy.
    Kim H; Park JH; Won KB; Yoon HJ; Park HS; Cho YK; Nam CW; Han S; Hur SH; Kim YN; Kim KB
    Heart; 2016 Aug; 102(15):1215-20. PubMed ID: 26969633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Long-Term Outcomes of Hypertrophic Cardiomyopathy.
    Yoshinaga M; Yoshikawa D; Ishii H; Hirashiki A; Okumura T; Kubota A; Sakai S; Harada K; Somura F; Mizuno T; Fujiwara W; Yokoi H; Hayashi M; Ishii J; Ozaki Y; Murohara T; Yoshida Y; Amano T; Izawa H
    Int Heart J; 2015; 56(4):415-20. PubMed ID: 26084460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of Serum Omentin-1 Levels for the Prediction of Adverse Cardiac Events in Patients with Hypertrophic Cardiomyopathy.
    Yıldız SS; Sahin I; Cetinkal G; Aksan G; Kucuk SH; Keskin K; Cetin S; Sigirci S; Avcı İİ; Kilci H; Kiliçkesmez K
    Med Princ Pract; 2018; 27(2):107-114. PubMed ID: 29402833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Bassiouny M; Lindsay BD; Lever H; Saliba W; Klein A; Banna M; Abraham J; Shao M; Rickard J; Kanj M; Tchou P; Dresing T; Baranowski B; Bhargava M; Callahan T; Tarakji K; Cantillon D; Hussein A; Marc Gillinov A; Smedira NG; Wazni O
    Heart Rhythm; 2015 Jul; 12(7):1438-47. PubMed ID: 25814420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke and Embolic Events in Hypertrophic Cardiomyopathy: Risk Stratification in Patients Without Atrial Fibrillation.
    Haruki S; Minami Y; Hagiwara N
    Stroke; 2016 Apr; 47(4):936-42. PubMed ID: 26941260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of cardiopulmonary exercise-derived scoring on prediction of cardio-cerebral outcome in hypertrophic cardiomyopathy.
    Lee JM; Park HB; Song JE; Kim IC; Song JH; Kim H; Oh J; Youn JC; Hong GR; Kang SM
    PLoS One; 2022; 17(1):e0259638. PubMed ID: 35030160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.